Read More Pharma Industry News How next-generation masking strategies could reshape PSMA-directed T cell engager development How Janux Therapeutics is advancing masked T cell engagers with JANX014. Find out what this means for prostate cancer treatment and immunotherapy. bySoujanya RaviApril 19, 2026